APO Research

APO RESEARCH · REPORT

0.9% Sodium Chloride Injection

0.9% Sodium Chloride Injection is a packaged sodium chloride solution for an identified medical-use specification.

Product & engineering

Understand the product.

Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which preparation and packaging specification is being purchased?

Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.

Selected research

Industry Research

0.9% Sodium Chloride Injection Industry Research Report 2026

Market perspective

The global 0.9% Sodium Chloride Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for 0.9% Sodium Chloride Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for 0.9% Sodium Chloride Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of 0.9% Sodium Chloride Injection include Southwest Pharmaceutical Co., Ltd., Tonghua Golden-horse Pharmaceutical Industry Co.,ltd., Jiangsu Suzhong PHARMA Group Co., Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., SSY Group Limited, Shandong Weigao Pharmaceutical Co., Ltd., Novartis and Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global 0.9% Sodium Chloride Injection market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

0.9% Sodium Chloride Injection Market by Company

Southwest Pharmaceutical Co., Ltd.

Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.

Jiangsu Suzhong PHARMA Group Co., Ltd.

Sichuan Kelun Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd.

SSY Group Limited

Shandong Weigao Pharmaceutical Co., Ltd.

Novartis

Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.

Jiangsu Sihuan Bioengineering Co.,Ltd.

Jiangsu Hengrui Pharmaceuticals Co.,ltd.

Jilin Province Dubang Pharmaceuticals Co., Ltd.

Pfizer

China Resources Double-crane Pharmaceutical Co.,Ltd.

Huaren Pharmaceutical Co.,Ltd.

Hebei TIANCHENG Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.

Fresenius Kabi

CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.

Cisen Pharmaceutical

PKU HealthCare Corp.,Ltd.

Baxter

Anhui Changjiang Pharmaceutical Co., Ltd.

Anhui Fengyuan Pharmaceutical Co.,Ltd.

Otsuka Pharmaceutical

BBraun

AstraZeneca plc.

Amphastar

0.9% Sodium Chloride Injection Segment by Type

100ml

250ml

500ml

Other

0.9% Sodium Chloride Injection Segment by Application

Hospitals

Clinics

Others

0.9% Sodium Chloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 0.9% Sodium Chloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 0.9% Sodium Chloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 0.9% Sodium Chloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of 0.9% Sodium Chloride Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of 0.9% Sodium Chloride Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of 0.9% Sodium Chloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 0.9% Sodium Chloride Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global 0.9% Sodium Chloride Injection Sales (m units) of Manufacturers (2021-2026) Table 7. Global 0.9% Sodium Chloride Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global 0.9% Sodium Chloride Injection Revenue of Manufacturers (2021-2026) Table 9. Global 0.9% Sodium Chloride Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market 0.9% Sodium Chloride Injection Average Price (US$/k unit) of Manufacturers (2021-2026) Table 11. Global 0.9% Sodium Chloride Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of 0.9% Sodium Chloride Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of 0.9% Sodium Chloride Injection, Product Type & Application Table 14. Global 0.9% Sodium Chloride Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global 0.9% Sodium Chloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Southwest Pharmaceutical Co., Ltd. Company Information Table 19. Southwest Pharmaceutical Co., Ltd. Business Overview Table 20. Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 21. Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 22. Southwest Pharmaceutical Co., Ltd. Recent Developments Table 23. Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Company Information Table 24. Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Business Overview Table 25. Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 26. Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 27. Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments Table 28. Jiangsu Suzhong PHARMA Group Co., Ltd. Company Information Table 29. Jiangsu Suzhong PHARMA Group Co., Ltd. Business Overview Table 30. Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 31. Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 32. Jiangsu Suzhong PHARMA Group Co., Ltd. Recent Developments Table 33. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information Table 34. Sichuan Kelun Pharmaceutical Co.,Ltd. Business Overview Table 35. Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 36. Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 37. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments Table 38. Sichuan Biokin Pharmaceutical Co.,Ltd. Company Information Table 39. Sichuan Biokin Pharmaceutical Co.,Ltd. Business Overview Table 40. Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 41. Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 42. Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments Table 43. SSY Group Limited Company Information Table 44. SSY Group Limited Business Overview Table 45. SSY Group Limited 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 46. SSY Group Limited 0.9% Sodium Chloride Injection Product Portfolio Table 47. SSY Group Limited Recent Developments Table 48. Shandong Weigao Pharmaceutical Co., Ltd. Company Information Table 49. Shandong Weigao Pharmaceutical Co., Ltd. Business Overview Table 50. Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 51. Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 52. Shandong Weigao Pharmaceutical Co., Ltd. Recent Developments Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 56. Novartis 0.9% Sodium Chloride Injection Product Portfolio Table 57. Novartis Recent Developments Table 58. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information Table 59. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview Table 60. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 61. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 62. Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments Table 63. Jiangsu Sihuan Bioengineering Co.,Ltd. Company Information Table 64. Jiangsu Sihuan Bioengineering Co.,Ltd. Business Overview Table 65. Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 66. Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 67. Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments Table 68. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information Table 69. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Business Overview Table 70. Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 71. Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 72. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments Table 73. Jilin Province Dubang Pharmaceuticals Co., Ltd. Company Information Table 74. Jilin Province Dubang Pharmaceuticals Co., Ltd. Business Overview Table 75. Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 76. Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 77. Jilin Province Dubang Pharmaceuticals Co., Ltd. Recent Developments Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 81. Pfizer 0.9% Sodium Chloride Injection Product Portfolio Table 82. Pfizer Recent Developments Table 83. China Resources Double-crane Pharmaceutical Co.,Ltd. Company Information Table 84. China Resources Double-crane Pharmaceutical Co.,Ltd. Business Overview Table 85. China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 86. China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 87. China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments Table 88. Huaren Pharmaceutical Co.,Ltd. Company Information Table 89. Huaren Pharmaceutical Co.,Ltd. Business Overview Table 90. Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 91. Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 92. Huaren Pharmaceutical Co.,Ltd. Recent Developments Table 93. Hebei TIANCHENG Pharmaceutical Co., Ltd. Company Information Table 94. Hebei TIANCHENG Pharmaceutical Co., Ltd. Business Overview Table 95. Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 96. Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 97. Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments Table 98. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 99. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 100. Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 101. Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 102. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments Table 103. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information Table 104. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview Table 105. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 106. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 107. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments Table 108. Fresenius Kabi Company Information Table 109. Fresenius Kabi Business Overview Table 110. Fresenius Kabi 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 111. Fresenius Kabi 0.9% Sodium Chloride Injection Product Portfolio Table 112. Fresenius Kabi Recent Developments Table 113. CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Company Information Table 114. CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Business Overview Table 115. CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 116. CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Product Portfolio Table 117. CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments Table 118. Cisen Pharmaceutical Company Information Table 119. Cisen Pharmaceutical Business Overview Table 120. Cisen Pharmaceutical 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 121. Cisen Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio Table 122. Cisen Pharmaceutical Recent Developments Table 123. PKU HealthCare Corp.,Ltd. Company Information Table 124. PKU HealthCare Corp.,Ltd. Business Overview Table 125. PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 126. PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 127. PKU HealthCare Corp.,Ltd. Recent Developments Table 128. Baxter Company Information Table 129. Baxter Business Overview Table 130. Baxter 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 131. Baxter 0.9% Sodium Chloride Injection Product Portfolio Table 132. Baxter Recent Developments Table 133. Anhui Changjiang Pharmaceutical Co., Ltd. Company Information Table 134. Anhui Changjiang Pharmaceutical Co., Ltd. Business Overview Table 135. Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 136. Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 137. Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments Table 138. Anhui Fengyuan Pharmaceutical Co.,Ltd. Company Information Table 139. Anhui Fengyuan Pharmaceutical Co.,Ltd. Business Overview Table 140. Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 141. Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio Table 142. Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments Table 143. Otsuka Pharmaceutical Company Information Table 144. Otsuka Pharmaceutical Business Overview Table 145. Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 146. Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio Table 147. Otsuka Pharmaceutical Recent Developments Table 148. BBraun Company Information Table 149. BBraun Business Overview Table 150. BBraun 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 151. BBraun 0.9% Sodium Chloride Injection Product Portfolio Table 152. BBraun Recent Developments Table 153. AstraZeneca plc. Company Information Table 154. AstraZeneca plc. Business Overview Table 155. AstraZeneca plc. 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 156. AstraZeneca plc. 0.9% Sodium Chloride Injection Product Portfolio Table 157. AstraZeneca plc. Recent Developments Table 158. Amphastar Company Information Table 159. Amphastar Business Overview Table 160. Amphastar 0.9% Sodium Chloride Injection Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 161. Amphastar 0.9% Sodium Chloride Injection Product Portfolio Table 162. Amphastar Recent Developments Table 163. Global 0.9% Sodium Chloride Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 164. Global 0.9% Sodium Chloride Injection Sales by Region (2021-2026) & (m units) Table 165. Global 0.9% Sodium Chloride Injection Sales Market Share by Region (2021-2026) Table 166. Global 0.9% Sodium Chloride Injection Sales by Region (2027-2032) & (m units) Table 167. Global 0.9% Sodium Chloride Injection Sales Market Share by Region (2027-2032) Table 168. Global 0.9% Sodium Chloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 169. Global 0.9% Sodium Chloride Injection Revenue Market Share by Region (2021-2026) Table 170. Global 0.9% Sodium Chloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 171. Global 0.9% Sodium Chloride Injection Revenue Market Share by Region (2027-2032) Table 172. North America 0.9% Sodium Chloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. North America 0.9% Sodium Chloride Injection Sales by Country (2021-2026) & (m units) Table 174. North America 0.9% Sodium Chloride Injection Sales by Country (2027-2032) & (m units) Table 175. North America 0.9% Sodium Chloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 176. North America 0.9% Sodium Chloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 177. Europe 0.9% Sodium Chloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Europe 0.9% Sodium Chloride Injection Sales by Country (2021-2026) & (m units) Table 179. Europe 0.9% Sodium Chloride Injection Sales by Country (2027-2032) & (m units) Table 180. Europe 0.9% Sodium Chloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 181. Europe 0.9% Sodium Chloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 182. Asia Pacific 0.9% Sodium Chloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Asia Pacific 0.9% Sodium Chloride Injection Sales by Country (2021-2026) & (m units) Table 184. Asia Pacific 0.9% Sodium Chloride Injection Sales by Country (2027-2032) & (m units) Table 185. Asia Pacific 0.9% Sodium Chloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 186. Asia Pacific 0.9% Sodium Chloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 187. South America 0.9% Sodium Chloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. South America 0.9% Sodium Chloride Injection Sales by Country (2021-2026) & (m units) Table 189. South America 0.9% Sodium Chloride Injection Sales by Country (2027-2032) & (m units) Table 190. South America 0.9% Sodium Chloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 191. South America 0.9% Sodium Chloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa 0.9% Sodium Chloride Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 193. Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2021-2026) & (m units) Table 194. Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2027-2032) & (m units) Table 195. Middle East and Africa 0.9% Sodium Chloride Injection Revenue by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa 0.9% Sodium Chloride Injection Revenue by Country (2027-2032) & (US$ Million) Table 197. Global 0.9% Sodium Chloride Injection Sales by Type (2021-2026) & (m units) Table 198. Global 0.9% Sodium Chloride Injection Sales by Type (2027-2032) & (m units) Table 199. Global 0.9% Sodium Chloride Injection Sales Market Share by Type (2021-2026) Table 200. Global 0.9% Sodium Chloride Injection Sales Market Share by Type (2027-2032) Table 201. Global 0.9% Sodium Chloride Injection Revenue by Type (2021-2026) & (US$ Million) Table 202. Global 0.9% Sodium Chloride Injection Revenue by Type (2027-2032) & (US$ Million) Table 203. Global 0.9% Sodium Chloride Injection Revenue Market Share by Type (2021-2026) Table 204. Global 0.9% Sodium Chloride Injection Revenue Market Share by Type (2027-2032) Table 205. Global 0.9% Sodium Chloride Injection Price by Type (2021-2026) & (US$/k unit) Table 206. Global 0.9% Sodium Chloride Injection Price by Type (2027-2032) & (US$/k unit) Table 207. Global 0.9% Sodium Chloride Injection Sales by Application (2021-2026) & (m units) Table 208. Global 0.9% Sodium Chloride Injection Sales by Application (2027-2032) & (m units) Table 209. Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2021-2026) Table 210. Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2027-2032) Table 211. Global 0.9% Sodium Chloride Injection Revenue by Application (2021-2026) & (US$ Million) Table 212. Global 0.9% Sodium Chloride Injection Revenue by Application (2027-2032) & (US$ Million) Table 213. Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2021-2026) Table 214. Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2027-2032) Table 215. Global 0.9% Sodium Chloride Injection Price by Application (2021-2026) & (US$/k unit) Table 216. Global 0.9% Sodium Chloride Injection Price by Application (2027-2032) & (US$/k unit) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. 0.9% Sodium Chloride Injection Distributors List Table 220. 0.9% Sodium Chloride Injection Customers List Table 221. 0.9% Sodium Chloride Injection Industry Trends Table 222. 0.9% Sodium Chloride Injection Industry Drivers Table 223. 0.9% Sodium Chloride Injection Industry Restraints Table 224. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. 0.9% Sodium Chloride Injection Product Image Figure 5. Global 0.9% Sodium Chloride Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global 0.9% Sodium Chloride Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global 0.9% Sodium Chloride Injection Sales (2021-2032) & (m units) Figure 8. Global 0.9% Sodium Chloride Injection Average Price (US$/k unit) & (2021-2032) Figure 9. 100ml Product Image Figure 10. 250ml Product Image Figure 11. 500ml Product Image Figure 12. Other Product Image Figure 13. Hospitals Product Image Figure 14. Clinics Product Image Figure 15. Others Product Image Figure 16. Global 0.9% Sodium Chloride Injection Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of 0.9% Sodium Chloride Injection, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 0.9% Sodium Chloride Injection Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global 0.9% Sodium Chloride Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global 0.9% Sodium Chloride Injection Sales by Region in 2025 Figure 22. Global 0.9% Sodium Chloride Injection Revenue by Region in 2025 Figure 23. North America 0.9% Sodium Chloride Injection Market Size by Country in 2025 Figure 24. North America 0.9% Sodium Chloride Injection Sales Market Share by Country (2021-2032) Figure 25. North America 0.9% Sodium Chloride Injection Revenue Market Share by Country (2021-2032) Figure 26. United States 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe 0.9% Sodium Chloride Injection Market Size by Country in 2025 Figure 30. Europe 0.9% Sodium Chloride Injection Sales Market Share by Country (2021-2032) Figure 31. Europe 0.9% Sodium Chloride Injection Revenue Market Share by Country (2021-2032) Figure 32. Germany 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific 0.9% Sodium Chloride Injection Market Size by Country in 2025 Figure 43. Asia Pacific 0.9% Sodium Chloride Injection Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific 0.9% Sodium Chloride Injection Revenue Market Share by Country (2021-2032) Figure 45. China 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America 0.9% Sodium Chloride Injection Market Size by Country in 2025 Figure 54. South America 0.9% Sodium Chloride Injection Sales Market Share by Country (2021-2032) Figure 55. South America 0.9% Sodium Chloride Injection Revenue Market Share by Country (2021-2032) Figure 56. Brazil 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa 0.9% Sodium Chloride Injection Market Size by Country in 2025 Figure 61. Middle East and Africa 0.9% Sodium Chloride Injection Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa 0.9% Sodium Chloride Injection Revenue Market Share by Country (2021-2032) Figure 63. Egypt 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries 0.9% Sodium Chloride Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global 0.9% Sodium Chloride Injection Sales Market Share by Type (2021-2032) Figure 69. Global 0.9% Sodium Chloride Injection Revenue Market Share by Type (2021-2032) Figure 70. Global 0.9% Sodium Chloride Injection Price (US$/k unit) by Type (2021-2032) Figure 71. Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2021-2032) Figure 72. Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2021-2032) Figure 73. Global 0.9% Sodium Chloride Injection Price (US$/k unit) by Application (2021-2032) Figure 74. 0.9% Sodium Chloride Injection Value Chain Figure 75. 0.9% Sodium Chloride Injection Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. 0.9% Sodium Chloride Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 100ml
  • 250ml
  • 500ml
  • Other
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Southwest Pharmaceutical Co., Ltd.
  • Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
  • Jiangsu Suzhong PHARMA Group Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co.,Ltd.
  • Sichuan Biokin Pharmaceutical Co.,Ltd.
  • SSY Group Limited
  • Shandong Weigao Pharmaceutical Co., Ltd.
  • Novartis
  • Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  • Jiangsu Sihuan Bioengineering Co.,Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co.,ltd.
  • Jilin Province Dubang Pharmaceuticals Co., Ltd.
  • Pfizer
  • China Resources Double-crane Pharmaceutical Co.,Ltd.
  • Huaren Pharmaceutical Co.,Ltd.
  • Hebei TIANCHENG Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
  • Fresenius Kabi
  • CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
  • Cisen Pharmaceutical
  • PKU HealthCare Corp.,Ltd.
  • Baxter
  • Anhui Changjiang Pharmaceutical Co., Ltd.
  • Anhui Fengyuan Pharmaceutical Co.,Ltd.
  • Otsuka Pharmaceutical
  • BBraun
  • AstraZeneca plc.
  • Amphastar

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global 0.9% Sodium Chloride Injection Market Size (2021-2032)
  4. 2.2.2 Global 0.9% Sodium Chloride Injection Sales (2021-2032)
  5. 2.2.3 Global 0.9% Sodium Chloride Injection Market Average Price (2021-2032)
  6. 2.3 0.9% Sodium Chloride Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 100ml
  9. 2.3.3 250ml
  10. 2.3.4 500ml
  11. 2.3.5 Other
  12. 2.4 0.9% Sodium Chloride Injection by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospitals
  15. 2.4.3 Clinics
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global 0.9% Sodium Chloride Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global 0.9% Sodium Chloride Injection Sales (m units) of Manufacturers (2021-2026)
  3. 3.3 Global 0.9% Sodium Chloride Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global 0.9% Sodium Chloride Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global 0.9% Sodium Chloride Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of 0.9% Sodium Chloride Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of 0.9% Sodium Chloride Injection, Product Type & Application
  8. 3.8 Global Manufacturers of 0.9% Sodium Chloride Injection, Established Date
  9. 3.9 Global 0.9% Sodium Chloride Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Southwest Pharmaceutical Co., Ltd.
  2. 4.1.1 Southwest Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  6. 4.1.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
  8. 4.2.1 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Company Information
  9. 4.2.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Business Overview
  10. 4.2.3 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
  12. 4.2.5 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments
  13. 4.3 Jiangsu Suzhong PHARMA Group Co., Ltd.
  14. 4.3.1 Jiangsu Suzhong PHARMA Group Co., Ltd. Company Information
  15. 4.3.2 Jiangsu Suzhong PHARMA Group Co., Ltd. Business Overview
  16. 4.3.3 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  18. 4.3.5 Jiangsu Suzhong PHARMA Group Co., Ltd. Recent Developments
  19. 4.4 Sichuan Kelun Pharmaceutical Co.,Ltd.
  20. 4.4.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
  21. 4.4.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Business Overview
  22. 4.4.3 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  24. 4.4.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments
  25. 4.5 Sichuan Biokin Pharmaceutical Co.,Ltd.
  26. 4.5.1 Sichuan Biokin Pharmaceutical Co.,Ltd. Company Information
  27. 4.5.2 Sichuan Biokin Pharmaceutical Co.,Ltd. Business Overview
  28. 4.5.3 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  30. 4.5.5 Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments
  31. 4.6 SSY Group Limited
  32. 4.6.1 SSY Group Limited Company Information
  33. 4.6.2 SSY Group Limited Business Overview
  34. 4.6.3 SSY Group Limited 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 SSY Group Limited 0.9% Sodium Chloride Injection Product Portfolio
  36. 4.6.5 SSY Group Limited Recent Developments
  37. 4.7 Shandong Weigao Pharmaceutical Co., Ltd.
  38. 4.7.1 Shandong Weigao Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Shandong Weigao Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  42. 4.7.5 Shandong Weigao Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Novartis
  44. 4.8.1 Novartis Company Information
  45. 4.8.2 Novartis Business Overview
  46. 4.8.3 Novartis 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Novartis 0.9% Sodium Chloride Injection Product Portfolio
  48. 4.8.5 Novartis Recent Developments
  49. 4.9 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
  50. 4.9.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  54. 4.9.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Jiangsu Sihuan Bioengineering Co.,Ltd.
  56. 4.10.1 Jiangsu Sihuan Bioengineering Co.,Ltd. Company Information
  57. 4.10.2 Jiangsu Sihuan Bioengineering Co.,Ltd. Business Overview
  58. 4.10.3 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  60. 4.10.5 Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments
  61. 4.11 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
  62. 4.11.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
  63. 4.11.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Business Overview
  64. 4.11.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
  66. 4.11.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
  67. 4.12 Jilin Province Dubang Pharmaceuticals Co., Ltd.
  68. 4.12.1 Jilin Province Dubang Pharmaceuticals Co., Ltd. Company Information
  69. 4.12.2 Jilin Province Dubang Pharmaceuticals Co., Ltd. Business Overview
  70. 4.12.3 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  72. 4.12.5 Jilin Province Dubang Pharmaceuticals Co., Ltd. Recent Developments
  73. 4.13 Pfizer
  74. 4.13.1 Pfizer Company Information
  75. 4.13.2 Pfizer Business Overview
  76. 4.13.3 Pfizer 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pfizer 0.9% Sodium Chloride Injection Product Portfolio
  78. 4.13.5 Pfizer Recent Developments
  79. 4.14 China Resources Double-crane Pharmaceutical Co.,Ltd.
  80. 4.14.1 China Resources Double-crane Pharmaceutical Co.,Ltd. Company Information
  81. 4.14.2 China Resources Double-crane Pharmaceutical Co.,Ltd. Business Overview
  82. 4.14.3 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  84. 4.14.5 China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments
  85. 4.15 Huaren Pharmaceutical Co.,Ltd.
  86. 4.15.1 Huaren Pharmaceutical Co.,Ltd. Company Information
  87. 4.15.2 Huaren Pharmaceutical Co.,Ltd. Business Overview
  88. 4.15.3 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  90. 4.15.5 Huaren Pharmaceutical Co.,Ltd. Recent Developments
  91. 4.16 Hebei TIANCHENG Pharmaceutical Co., Ltd.
  92. 4.16.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  96. 4.16.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  98. 4.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  102. 4.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
  104. 4.18.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information
  105. 4.18.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
  106. 4.18.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  108. 4.18.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments
  109. 4.19 Fresenius Kabi
  110. 4.19.1 Fresenius Kabi Company Information
  111. 4.19.2 Fresenius Kabi Business Overview
  112. 4.19.3 Fresenius Kabi 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Fresenius Kabi 0.9% Sodium Chloride Injection Product Portfolio
  114. 4.19.5 Fresenius Kabi Recent Developments
  115. 4.20 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
  116. 4.20.1 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Company Information
  117. 4.20.2 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Business Overview
  118. 4.20.3 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Product Portfolio
  120. 4.20.5 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments
  121. 4.21 Cisen Pharmaceutical
  122. 4.21.1 Cisen Pharmaceutical Company Information
  123. 4.21.2 Cisen Pharmaceutical Business Overview
  124. 4.21.3 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
  126. 4.21.5 Cisen Pharmaceutical Recent Developments
  127. 4.22 PKU HealthCare Corp.,Ltd.
  128. 4.22.1 PKU HealthCare Corp.,Ltd. Company Information
  129. 4.22.2 PKU HealthCare Corp.,Ltd. Business Overview
  130. 4.22.3 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  132. 4.22.5 PKU HealthCare Corp.,Ltd. Recent Developments
  133. 4.23 Baxter
  134. 4.23.1 Baxter Company Information
  135. 4.23.2 Baxter Business Overview
  136. 4.23.3 Baxter 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Baxter 0.9% Sodium Chloride Injection Product Portfolio
  138. 4.23.5 Baxter Recent Developments
  139. 4.24 Anhui Changjiang Pharmaceutical Co., Ltd.
  140. 4.24.1 Anhui Changjiang Pharmaceutical Co., Ltd. Company Information
  141. 4.24.2 Anhui Changjiang Pharmaceutical Co., Ltd. Business Overview
  142. 4.24.3 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  144. 4.24.5 Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments
  145. 4.25 Anhui Fengyuan Pharmaceutical Co.,Ltd.
  146. 4.25.1 Anhui Fengyuan Pharmaceutical Co.,Ltd. Company Information
  147. 4.25.2 Anhui Fengyuan Pharmaceutical Co.,Ltd. Business Overview
  148. 4.25.3 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
  150. 4.25.5 Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments
  151. 4.26 Otsuka Pharmaceutical
  152. 4.26.1 Otsuka Pharmaceutical Company Information
  153. 4.26.2 Otsuka Pharmaceutical Business Overview
  154. 4.26.3 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
  156. 4.26.5 Otsuka Pharmaceutical Recent Developments
  157. 4.27 BBraun
  158. 4.27.1 BBraun Company Information
  159. 4.27.2 BBraun Business Overview
  160. 4.27.3 BBraun 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 BBraun 0.9% Sodium Chloride Injection Product Portfolio
  162. 4.27.5 BBraun Recent Developments
  163. 4.28 AstraZeneca plc.
  164. 4.28.1 AstraZeneca plc. Company Information
  165. 4.28.2 AstraZeneca plc. Business Overview
  166. 4.28.3 AstraZeneca plc. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 AstraZeneca plc. 0.9% Sodium Chloride Injection Product Portfolio
  168. 4.28.5 AstraZeneca plc. Recent Developments
  169. 4.29 Amphastar
  170. 4.29.1 Amphastar Company Information
  171. 4.29.2 Amphastar Business Overview
  172. 4.29.3 Amphastar 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 Amphastar 0.9% Sodium Chloride Injection Product Portfolio
  174. 4.29.5 Amphastar Recent Developments
5 Global 0.9% Sodium Chloride Injection Market Scenario by Region
  1. 5.1 Global 0.9% Sodium Chloride Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global 0.9% Sodium Chloride Injection Sales by Region: 2021-2032
  3. 5.2.1 Global 0.9% Sodium Chloride Injection Sales by Region: 2021-2026
  4. 5.2.2 Global 0.9% Sodium Chloride Injection Sales by Region: 2027-2032
  5. 5.3 Global 0.9% Sodium Chloride Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global 0.9% Sodium Chloride Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global 0.9% Sodium Chloride Injection Revenue by Region: 2027-2032
  8. 5.4 North America 0.9% Sodium Chloride Injection Market Facts & Figures by Country
  9. 5.4.1 North America 0.9% Sodium Chloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
  11. 5.4.3 North America 0.9% Sodium Chloride Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe 0.9% Sodium Chloride Injection Market Facts & Figures by Country
  16. 5.5.1 Europe 0.9% Sodium Chloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe 0.9% Sodium Chloride Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific 0.9% Sodium Chloride Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific 0.9% Sodium Chloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific 0.9% Sodium Chloride Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America 0.9% Sodium Chloride Injection Market Facts & Figures by Country
  41. 5.7.1 South America 0.9% Sodium Chloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
  43. 5.7.3 South America 0.9% Sodium Chloride Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa 0.9% Sodium Chloride Injection Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa 0.9% Sodium Chloride Injection Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa 0.9% Sodium Chloride Injection Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global 0.9% Sodium Chloride Injection Sales by Type (2021-2032)
  2. 6.1.1 Global 0.9% Sodium Chloride Injection Sales by Type (2021-2032) & (m units)
  3. 6.1.2 Global 0.9% Sodium Chloride Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global 0.9% Sodium Chloride Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global 0.9% Sodium Chloride Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global 0.9% Sodium Chloride Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global 0.9% Sodium Chloride Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global 0.9% Sodium Chloride Injection Sales by Application (2021-2032)
  2. 7.1.1 Global 0.9% Sodium Chloride Injection Sales by Application (2021-2032) & (m units)
  3. 7.1.2 Global 0.9% Sodium Chloride Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global 0.9% Sodium Chloride Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global 0.9% Sodium Chloride Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global 0.9% Sodium Chloride Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global 0.9% Sodium Chloride Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 0.9% Sodium Chloride Injection Value Chain Analysis
  2. 8.1.1 0.9% Sodium Chloride Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 0.9% Sodium Chloride Injection Production Mode & Process
  5. 8.2 0.9% Sodium Chloride Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 0.9% Sodium Chloride Injection Distributors
  8. 8.2.3 0.9% Sodium Chloride Injection Customers
9 Global 0.9% Sodium Chloride Injection Analyzing Market Dynamics
  1. 9.1 0.9% Sodium Chloride Injection Industry Trends
  2. 9.2 0.9% Sodium Chloride Injection Industry Drivers
  3. 9.3 0.9% Sodium Chloride Injection Industry Opportunities and Challenges
  4. 9.4 0.9% Sodium Chloride Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research